ArticleStructure (London, England : 1993)2026
A mechanistic understanding of how KCNE1 tunes KCNQ1 channel pharmacology.
Article in Structure (London, England : 1993), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The IKs potassium channel that is essential for cardiac repolarization is formed by KCNQ1 and KCNE1 subunits. Promising activators of KCNQ1 need to affect KCNQ1-KCNE1 to be used as therapeutics to prevent cardiac arrythmia. Unfortunately, KCNE1 dramatically impairs several KCNQ1 activators. How KCNE1 changes the sensitivity of KCNQ1 to various compounds is unknown, limiting rational design of IKs channel activators. KCNE1 has been proposed to induce a conformational change in the S5-P loop of KCNQ1. Here, we examine the effects of K285Q in the S5-P loop on the sensitivity of KCNQ1 and IKs to polyunsaturated fatty acid (PUFA) analogs. We find that K285Q causes PUFA analogs to have different effects in KCNQ1 versus IKs, suggesting that the S5-P loop moves between two different PUFA sites when KCNE1 associates with KCNQ1. This will allow for a mechanistic framework to design IKs channel activators that circumvent KCNE1-induced impairment of drug binding.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.